Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pejvakin (PJVK) is a vertebrate-specific, 352-amino acid protein and a distantly related member of the gasdermin family, characterized by a conserved N-terminal gasdermin domain. It plays a critical role in the auditory system in two main contexts: maintenance of hair cell stereocilia architecture and neural auditory signal transmission. Pejvakin localizes to the rootlets of stereocilia in hair cells, where it interacts with TRIOBP and is essential for maintaining the structural integrity and mechanosensory function of the hair bundle. It is also required for a specialized autophagy pathway (pexophagy), promoting peroxisome proliferation to protect auditory neurons and hair cells against oxidative damage induced by noise exposure. Mutations in PJVK cause autosomal recessive non-syndromic hearing loss DFNB59, with phenotypes ranging from auditory neuropathy to cochlear deafness. Pejvakin's critical role in auditory function makes it a key diagnostic biomarker and a potential, though challenging, therapeutic target[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pejvakin (PJVK).